Abbott Laboratories leveled up on this year’s Fortune 500 list, leaping from last year’s rank of 104 to No. 89. Why? COVID testing. Abbott was one of the first to jump into the testing market, and that alacrity has paid off; the company’s diagnostics unit, which also houses its COVID test arm, raked in more than $4 billion in sales during the first quarter of 2021 alone. Abbott, though, isn’t putting all its eggs in one basket. As life starts returning to normal, the company believes its diabetes care and glucose monitoring products will continue to fuel growth.
Lists ranking Abbott Laboratories
RANK20
28 Best Large Workplaces in Health Care - 2021The best U.S. health care companies with more than...view in list
RANK42
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...view in list
Latest news for Abbott Laboratories
- HealthRapid COVID tests are coming to market alongside vaccines to help America return to normalApril 1, 2021 6:45 PM UTC
- LeadershipHow Abbott, Merck, and more health care and biopharma companies took care during COVIDMarch 12, 2021 12:00 PM UTC
- HealthThe CDC says antibody tests shouldn’t be used to make return-to-work decisionsMay 27, 2020 8:15 PM UTC